151 related articles for article (PubMed ID: 10448603)
1. Multiple chromosomal abnormalities in fulminant anaplastic myeloma.
Maslovsky I; Lugassy G; Blumental R; Ducach A; Yehuda O; Abeliovich D
Clin Lab Haematol; 1999 Jun; 21(3):207-10. PubMed ID: 10448603
[TBL] [Abstract][Full Text] [Related]
2. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).
Sato K; Sakai H; Kato M; Nishio Y; Tsuruoka Y; Uemura Y; Yokoi S; Saito T; Matsunawa M; Suzuki Y; Isobe Y; Inoue Y; Takahashi M; Miura I
Int J Hematol; 2015 Jun; 101(6):608-11. PubMed ID: 25633778
[TBL] [Abstract][Full Text] [Related]
3. Plasma cell karyotype in multiple myeloma.
Gould J; Alexanian R; Goodacre A; Pathak S; Hecht B; Barlogie B
Blood; 1988 Feb; 71(2):453-6. PubMed ID: 3337907
[TBL] [Abstract][Full Text] [Related]
4. Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial.
Nemec P; Zemanova Z; Kuglik P; Michalova K; Tajtlova J; Kaisarova P; Oltova A; Filkova H; Holzerova M; Balcarkova J; Jarosova M; Rabasova J; Hruba M; Spicka I; Gregora E; Adam Z; Scudla V; Maisnar V; Schutzova M; Hajek R;
Leuk Lymphoma; 2012 May; 53(5):920-7. PubMed ID: 22023516
[TBL] [Abstract][Full Text] [Related]
5. Karyotype in multiple myeloma and plasma cell leukaemia.
Weh HJ; Gutensohn K; Selbach J; Kruse R; Wacker-Backhaus G; Seeger D; Fiedler W; Fett W; Hossfeld DK
Eur J Cancer; 1993; 29A(9):1269-73. PubMed ID: 8343266
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the PRAD1 oncogene in a patient with multiple myeloma and t(11;14)(q13;q32).
Kobayashi H; Saito H; Kitano K; Kiyosawa K; Gaun S; Aoki K; Narita A; Watanabe M; Uchimaru K; Motokura T
Acta Haematol; 1995; 94(4):199-203. PubMed ID: 8610478
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetics of multiple myeloma.
Trcić RL; Skelin IK; Sustercić D; Planinc-Peraica A; Ajduković R; Haris V; Kusec R; Begović D
Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
[TBL] [Abstract][Full Text] [Related]
8. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes.
Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A
Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of a cytogenetically complex Chinese multiple myeloma-derived cell line with homozygous p53 deletion and cyclin E overexpression.
Cheng SH; Ng MH; Tsang KS; Lau KM; Chan JC; Liu HS; Chu RW; Poon CS; Ng HK
Int J Oncol; 2004 May; 24(5):1141-8. PubMed ID: 15067335
[TBL] [Abstract][Full Text] [Related]
10. A variant Burkitt-type translocation (8;22)(q24;q11) in multiple myeloma. Report of a new case and review of the literature.
Yamamoto K; Hamaguchi H; Nagata K; Taniwaki M
Cancer Genet Cytogenet; 1998 Jul; 104(2):98-103. PubMed ID: 9666801
[TBL] [Abstract][Full Text] [Related]
11. Two cases of t(1;16)(p11;p11) in multiple myeloma: confirmation by chromosome painting.
Flactif M; Laï JL; Zandecki M; Bernardi F; Trillot N; Bauters F; Facon T
Cancer Genet Cytogenet; 1994 Aug; 76(1):10-4. PubMed ID: 8076342
[TBL] [Abstract][Full Text] [Related]
12. Multiple myeloma with a variant Burkitt-type translocation, t(2;8)(p12;q24), associated with hyperammonemia.
Yamamoto Y; Konoike Y; Nakamine H; Nakamura S; Morii T; Kimura H
Intern Med; 2009; 48(14):1239-42. PubMed ID: 19602793
[TBL] [Abstract][Full Text] [Related]
13. The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study.
Hoyer JD; Hanson CA; Fonseca R; Greipp PR; Dewald GW; Kurtin PJ
Am J Clin Pathol; 2000 Jun; 113(6):831-7. PubMed ID: 10874884
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal aberrations of multiple myeloma in Chinese patients at diagnosis: a study by combined G-banding and multicolor spectral karyotyping.
Ng MH; Wong N; Lau TT; Tsang KS; Cheng SH; Chan NP; Tang SH; Lei KI; Leung Y
Oncol Rep; 2003; 10(3):587-91. PubMed ID: 12684628
[TBL] [Abstract][Full Text] [Related]
15. Variant Burkitt-type translocation (8;22)(q24;q11) in plasma cell myeloma.
Kim H; Moon HW; Hur M; Yun YM; Park CM; Lee MH
Korean J Hematol; 2011 Jun; 46(2):135-8. PubMed ID: 21747887
[TBL] [Abstract][Full Text] [Related]
16. Der(16)t(1;16)(q10;p10) in multiple myeloma: a new non-random abnormality that is frequently associated with Burkitt's-type translocations.
Mugneret F; Sidaner I; Favre B; Manone L; Maynadié M; Caillot D; Solary E
Leukemia; 1995 Feb; 9(2):277-81. PubMed ID: 7869764
[TBL] [Abstract][Full Text] [Related]
17. High incidence of chromosome abnormalities in IgG3 myeloma.
Van den Berghe H; Vermaelen K; Louwagie A; Criel A; Mecucci C; Vaerman JP
Cancer Genet Cytogenet; 1984 Apr; 11(4):381-7. PubMed ID: 6704939
[TBL] [Abstract][Full Text] [Related]
18. Multiple unrelated clonal chromosome abnormalities in an in situ squamous cell carcinoma of the skin.
Heim S; Jin Y; Mandahl N; Biörklund A; Wennerberg J; Jonsson N; Mitelman F
Cancer Genet Cytogenet; 1988 Dec; 36(2):149-53. PubMed ID: 3203301
[TBL] [Abstract][Full Text] [Related]
19. Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load.
Neben K; Jauch A; Hielscher T; Hillengass J; Lehners N; Seckinger A; Granzow M; Raab MS; Ho AD; Goldschmidt H; Hose D
J Clin Oncol; 2013 Dec; 31(34):4325-32. PubMed ID: 24145347
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
Wu KL; Beverloo B; Lokhorst HM; Segeren CM; van der Holt B; Steijaert MM; Westveer PH; Poddighe PJ; Verhoef GE; Sonneveld P; ;
Br J Haematol; 2007 Feb; 136(4):615-23. PubMed ID: 17223915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
